Identification of prognostic imaging biomarkers in H3 K27-altered diffuse midline gliomas in adults: impact of tumor oxygenation imaging biomarkers on survival
View abstract on PubMed
Summary
This summary is machine-generated.Leptomeningeal metastases (LM) predict poor prognosis in adult H3 K27-altered diffuse midline gliomas (DMGs). In contrast-enhancing tumors, higher relative cerebral metabolic rate of oxygen (rCMRO2) also indicates a worse outcome.
Area Of Science
- Neuro-oncology
- Radiology
- Oncology
Background
- Diffuse midline gliomas (DMGs) with H3 K27 alterations are aggressive brain tumors.
- Identifying prognostic markers is crucial for managing adult patients with these rare tumors.
Purpose Of The Study
- To investigate clinical, qualitative, and quantitative imaging markers, including tumor oxygenation, for predicting prognosis in adult H3 K27-altered DMGs.
- To identify independent predictors of overall survival (OS).
Main Methods
- Retrospective review of 32 adult patients with H3 K27-altered DMGs.
- Analysis of clinical and qualitative imaging features.
- Quantitative imaging assessment of tumor oxygenation (nCBV, CTH, OEF, rCMRO2) and ADC values.
- Cox proportional hazards models to identify predictors of OS.
Main Results
- Leptomeningeal metastases (LM) were the sole independent predictor of OS in all patients (HR=6.01, P=0.009).
- In patients with contrast-enhancing (CE) tumors, LM (HR=5.92, P=0.043) and higher rCMRO2 (HR=1.08, P=0.019) independently predicted poor OS.
Conclusions
- Leptomeningeal metastases (LM) are a significant independent predictor of poor prognosis in adult H3 K27-altered DMG.
- Elevated rCMRO2 in CE tumors may serve as a valuable imaging biomarker for predicting poor prognosis, reflecting increased metabolic activity and altered tumor oxygenation.

